<DOC>
	<DOCNO>NCT00459277</DOCNO>
	<brief_summary>Cancer patient take regular medication pain often still episodes severe pain 'break ' despite background pain treatment . Fentanyl strong , short-acting pain killer often use treat 'breakthrough ' pain . Nasalfent contain fentanyl patent drug delivery system call PecSys give via simple nasal spray . This study test efficacy safety Nasalfent treatment breakthrough cancer pain .</brief_summary>
	<brief_title>Efficacy &amp; Safety Study Nasalfent ( Fentanyl Citrate Nasal Spray ) Treatment Breakthrough Cancer Pain Patients Taking Regular Opioids</brief_title>
	<detailed_description>Current treatment breakthrough cancer pain ( BTCP ) work slowly meet fast onset BTCP episodes , continue act long episode pain last unwanted side effect due 'over treatment ' pain episode . In addition cancer patient oral problem make take pain relief medication mouth uncomfortable patient . Nasalfent administer via nose simple spray take patient give carers . The nasal route common way administer medication example treatment migraine allergy . At time study patient may take regular treatment BTCP wish . This study compare time onset degree pain relief Nasalfent Placebo . The safety two treatment group ( Nasalfent , Placebo ) also examine .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Able willing give consent Women childbearing potential must ) negative urine pregnancy test b ) breast feed c ) agree practice reliable form contraception Diagnosis cancer Taking least 60mg oral morphine equivalent 24 hour treatment cancerrelated pain Experiencing average 1 4 episode breakthrough cancer pain per day usually control rescue pain medication Able ( via caregiver ) evaluate record pain relief , assess medication performance set time dose , record adverse event , record use study drug rescue medication diary Able 50 % day great Intolerance opioids fentanyl rapidly increasing/uncontrolled pain pain cancer relate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Pain</keyword>
	<keyword>Cancer</keyword>
</DOC>